跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aprovel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aprovel
Approved
STANDARD
Aprovel
Sanofi Winthrop Industrie
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc4c90a60cb43bea
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
fc4c90a60cb43bea
Drug Approval Philippines Name
Aprovel
Product Name
Aprovel
Registration Number
DRP-5715
Brand Name
Aprovel
Generic Name
Irbesartan
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Sanofi Winthrop Industrie
Importer
Sanofi-Aventis Philippines, Inc.
Company Detail Path
/organization/sanofi-winthrop-industrie
Issuance Date
29 March 2022
Expiry Date
03 May 2027
Pharmacologic Category
ANGIOTENSIN-2-RECEPTOR BLOCKER (ARB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc4c90a60cb43bea
Type
Standard
Back to Philippines FDA Approvals